Skip to main content
Download PDF
- Main
Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
- Daud, Adil I;
- Loo, Kimberly;
- Pauli, Mariela L;
- Sanchez-Rodriguez, Robert;
- Sandoval, Priscila Munoz;
- Taravati, Keyon;
- Tsai, Katy;
- Nosrati, Adi;
- Nardo, Lorenzo;
- Alvarado, Michael D;
- Algazi, Alain P;
- Pampaloni, Miguel H;
- Lobach, Iryna V;
- Hwang, Jimmy;
- Pierce, Robert H;
- Gratz, Iris K;
- Krummel, Matthew F;
- Rosenblum, Michael D
- et al.
Published Web Location
https://doi.org/10.1172/jci87324Abstract
Background
Immune checkpoint blockade is revolutionizing therapy for advanced cancer, but many patients do not respond to treatment. The identification of robust biomarkers that predict clinical response to specific checkpoint inhibitors is critical in order to stratify patients and to rationally select combinations in the context of an expanding array of therapeutic options.Methods
We performed multiparameter flow cytometry on freshly isolated metastatic melanoma samples from 2 cohorts of 20 patients each prior to treatment and correlated the subsequent clinical response with the tumor immune phenotype.Results
Increasing fractions of programmed cell death 1 high/cytotoxic T lymphocyte-associated protein 4 high (PD-1hiCTLA-4hi) cells within the tumor-infiltrating CD8+ T cell subset strongly correlated with response to therapy (RR) and progression-free survival (PFS). Functional analysis of these cells revealed a partially exhausted T cell phenotype. Assessment of metastatic lesions during anti-PD-1 therapy demonstrated a release of T cell exhaustion, as measured by an accumulation of highly activated CD8+ T cells within tumors, with no effect on Tregs.Conclusions
Our data suggest that the relative abundance of partially exhausted tumor-infiltrating CD8+ T cells predicts response to anti-PD-1 therapy. This information can be used to appropriately select patients with a high likelihood of achieving a clinical response to PD-1 pathway inhibition.Funding
This work was funded by a generous gift provided by Inga-Lill and David Amoroso as well as a generous gift provided by Stephen Juelsgaard and Lori Cook.Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%